Neurocognitive and psychological contributions to quality of life in HIV-1-infected women

被引:49
作者
Osowiecki, DM
Cohen, RA
Morrow, KM
Paul, RH
Carpenter, CCJ
Flanigan, T
Boland, RJ
机构
[1] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA
[2] Brown Univ, Sch Med, Dept Immunol, Providence, RI 02912 USA
关键词
neurocognitive impairment; quality of life; HIV; CD4; immune function; Profile of Mood States;
D O I
10.1097/00002030-200007070-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: The purpose of this study was to examine the impact of neurocognitive and emotional distress and immune system dysfunction on quality of life in women with HIV. Methods: Thirty-six HIV-seropositive women were administered measures of mood status (Profile of Mood States), quality of life (Multidimensional Quality of Life Questionnaire for Persons with HIV) and cognitive function. CD4 cell counts were obtained as an indicator of immune system status. Results: Regression analyses revealed that independent of severity of emotional distress, neurocognitive deficits on measures of executive control and speed of information processing were associated with reduced quality of life. Emotional status also was associated with quality of life and together with neurocognitive performance accounted for most of the variance associated with quality of life. Reduced CD4 cell count was significantly associated with neurocognitive deficits, but not severity of emotional distress or quality of life. Conclusions: Quality of life among women who are infected with HIV is strongly influenced by both neurocognitive and emotional status, as women with the greatest neurocognitive impairment and emotional distress report the poorest quality of life. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1327 / 1332
页数:6
相关论文
共 43 条
[1]   PSYCHONEUROIMMUNOLOGY AND HIV-1 [J].
ANTONI, MH ;
SCHNEIDERMAN, N ;
FLETCHER, MA ;
GOLDSTEIN, DA ;
IRONSON, G ;
LAPERRIERE, A .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) :38-49
[2]  
AVIS NE, UNPUB COMMUNICATION
[3]  
BORNSTEIN RA, 1994, J NEUROPSYCH CLIN N, V6, P160
[4]   RATE OF CD4 DECLINE AND NEUROPSYCHOLOGICAL PERFORMANCE IN HIV-INFECTION [J].
BORNSTEIN, RA ;
NASRALLAH, HA ;
PARA, MF ;
FASS, RJ ;
WHITACRE, CC ;
RICE, RR .
ARCHIVES OF NEUROLOGY, 1991, 48 (07) :704-707
[5]  
BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO
[6]  
2-C
[7]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[8]  
CELLA D F, 1989, Journal of Psychosocial Oncology, V7, P45, DOI 10.1300/J077v07n01_04
[9]   TRIPARTITE MODEL OF ANXIETY AND DEPRESSION - PSYCHOMETRIC EVIDENCE AND TAXONOMIC IMPLICATIONS [J].
CLARK, LA ;
WATSON, D .
JOURNAL OF ABNORMAL PSYCHOLOGY, 1991, 100 (03) :316-336
[10]  
COHEN RA, 1999, AM J CARDIOL